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Introduction: The development of acute kidney injury (AKI) is associated with poor outcome. The modified RIFLE
(risk, injury, failure, loss of kidney function, and end-stage renal failure) classification for AKI, which classifies patients
with renal replacement therapy needs according to RIFLE failure class, improves the predictive value of AKI in
patients undergoing cardiac surgery. Our aim was to assess risk factors for post-operative AKI and the impact of
renal function on short- and long-term survival among all AKI subgroups using the modified RIFLE classification.
Methods: We prospectively studied 2,940 consecutive cardiosurgical patients between January 2004 and July 2009.
AKI was defined according to the modified RIFLE system. Pre-operative, operative and post-operative variables usually
measured on and during admission, which included main outcomes, were recorded together with cardiac surgery scores
and ICU scores. These data were evaluated for association with AKI and staging in the different RIFLE groups by means
of multivariable analyses. Survival was analyzed via Kaplan-Meier and a risk-adjusted Cox proportional hazards regression
model. A complete follow-up (mean 6.9 ± 4.3 years) was performed in 2,840 patients up to April 2013.
Results: Of those patients studied, 14% (n = 409) were diagnosed with AKI. We identified one intra-operative (higher
cardiopulmonary bypass time) and two post-operative (a longer need for vasoactive drugs and higher arterial lactate 24
hours after admission) predictors of AKI. The worst outcomes, including in-hospital mortality, were associated with the
worst RIFLE class. Kaplan-Meier analysis showed survival of 74.9% in the RIFLE risk group, 42.9% in the RIFLE injury group
and 22.3% in the RIFLE failure group (P <0.001). Classification at RIFLE injury (Hazard ratio (HR) = 2.347, 95% confidence
interval (CI) 1.122 to 4.907, P = 0.023) and RIFLE failure (HR = 3.093, 95% CI 1.460 to 6.550, P = 0.003) were independent
predictors for long-term patient mortality.
Conclusions: AKI development after cardiac surgery is associated mainly with post-operative variables, which ultimately
could lead to a worst RIFLE class. Staging at the RIFLE injury and RIFLE failure class is associated with higher short- and
long-term mortality in our population.* Correspondence: juancarloslopezde@hotmail.com
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The development of acute kidney injury (AKI) after
adult cardiac surgery is associated with higher morbidity
and mortality [1-3]. AKI develops in 1% to 30% of these
patients, depending on the definition used for AKI [4],
and leads to renal replacement therapy (RRT) in 1% to
5% [5]. Previous reports have studied risk factors associ-
ated with the occurrence of AKI, mainly focusing on
factors measurable before surgery [6,7] or during the
perioperative period [1]. However, postoperative man-
agement in the intensive care unit (ICU) could also be
relevant for the occurrence of AKI after cardiac surgery.
In addition, factors that are measurable postoperatively
may indicate AKI development, suggesting appropriate
strategies to prevent or limit AKI.
The RIFLE (Risk, Injury, Failure, Loss of kidney func-
tion, and End-stage renal failure) classification indicates
AKI severity based on changes in serum creatinine (sCr)
relative to the baseline condition, its association with
short-term mortality after cardiac surgery having been
validated previously [8-10]. Recently, a modification of the
RIFLE classification by staging all patients with acute need
for RRT in the failure class F showed an improvement of
the predictive value for AKI in patients undergoing cardiac
surgery, being superior to acute kidney injury network
criteria (AKIN) if there is no correction of sCr for fluid
balance, which leads to over-diagnosis of AKI [3]. In
addition, data on long-term survival after AKI in these
patients are scarce despite the need for such information.
The aim of this study was: (1) to identify the risk fac-
tors for AKI, especially regarding postoperative variables,
and the predictive value for AKI of preoperative and
postoperative scores; and (2) to evaluate the long-term
mortality risk associated with a modified RIFLE classifi-
cation after cardiac surgery in a large single-center
cohort of patients with no history of chronic kidney
disease, together with an evaluation of the variables that
influence staging in the different RIFLE groups.
Methods
This study was a retrospective study of prospectively col-
lected data from 2,940 consecutive patients undergoing
different types of cardiac surgery between January 2004
and July 2009 at our institution. We excluded those with
preoperative renal failure requiring dialysis (n =24) or
chronic kidney disease (CKD) (n = 144). Heart-transplant
patients (n = 124) were also excluded due to the higher
AKI rates reported in previous studies, which may lead
to bias [2]. Definition of CKD was based on the Society
of Thoracic Surgeons’ national cardiac surgery database
definitions, which is defined as a serum creatinine value
of 2.0 mg/dL (176.8 mmol · L-1) or greater.
The study was approved by the Institutional Ethics
Committee of our hospital (Comité d’ Ètica i AssajosClínics de Hospital Universitari de Bellvitge (CEIC); Ethics
and Clinical Assays Committee of Hospital Universitari de
Bellvitge). Informed consent was waived due to the obser-
vational nature of our study. The follow-up was performed
using the Catalan Health Central Registry (Registre Central
de Persones Assegurades, RCA). A complete follow-up was
performed in 2,840 patients up to April 2013.
Data on and during ICU admission were extracted
from the medical registry of each patient in real time
using a standardized questionnaire and collected in a
database for analysis purposes. Recent myocardial infarc-
tion (AMI) was defined as an AMI that required admis-
sion to the hospital during the last month before surgery
or an AMI that did not allow discharge from the hos-
pital before surgery. The other definitions used for this
study were based on the Society of Thoracic Surgeons’
national cardiac surgery database definitions [11].
Preoperative data (demographic data, comorbidities
and treatment before surgery), operative data and post-
operative variables usually measured on and during
admission, which included main outcomes, were re-
corded together with cardiac surgery scores (Parsonnet,
European System for Cardiac Operative Risk Evaluation
(EuroSCORE)) and ICU scores (Acute Physiology and
Chronic Health Evaluation (APACHE) II and III, Simpli-
fied Acute Physiology Score (SAPS) II and III).
AKI was defined according to the RIFLE classification
[8-10]. The baseline sCr is based on the preoperative
analysis 24 h before surgery. Patients who met the RIFLE
criteria for AKI were classified as “AKI”, whereas those
who did not were classified as “no AKI”. Patients with
AKI were stratified according to the RIFLE class; all
patients with acute RRT were assigned to failure class
F [3]. We measured the patients’ sCr at admission, 6 h,
12 h and 24 h postoperatively and a minimum of twice
per day during their stay in the ICU based on our unit
protocols.
The operations were performed by the same group
of cardiac surgeons during the study period. Cardiac
procedures were performed in all patients using median
sternotomy, standard cardiopulmonary bypass (CPB) with
moderate hypothermia (34°C) and antegrade cardiople-
gia. A mean aortic pressure of >60 mmHg was main-
tained during surgery. For revascularization, we used
the internal thoracic artery (or bilateral if possible)
and saphenous vein grafts. Bypass graft flow was assessed
for each graft by Doppler transit time flowmetry. Pro-
tamine was administered to reverse heparin according
to standard practice. For coronary artery bypass graft
(CABG) surgery, aspirin was routinely administered
within the first 6 h after surgery following the local
protocol. In all patients the decisions regarding post-
operative ICU management were made by the attending
physician.
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Statistical analysis was conducted using PASW statistics
13.0 (SPSS Inc., Chicago, IL, USA). Data are expressed
as mean ± standard deviation. In order to evaluate differ-
ences regarding risk factors for AKI we analyzed differ-
ences between groups that were determined according
to the presence of AKI after cardiac surgery. For com-
parisons between groups the Mann–Whitney U test was
used or, when appropriate, the two-sample t-test. The
χ2-test was used to evaluate categorical prognostic
factors. A multivariate analysis was carried out using a
stepwise logistic regression model to identify independ-
ent risk factors for AKI after cardiac surgery afterTable 1 Univariate analysis of preoperative data associated w
All patients
(n = 2,940)
Sex (male) 64.0% (1,881)
Sex (female) 36.0% (1,059)
Age (years) 64.5 ± 11.6
Hypertension 62.8% (1,846)
Dyslipidemia 50.5% (1,484)
Diabetes mellitus 8.2% (241)
BMI (kg · m-2) 28.1 ± 4.3
Peripheral vascular disease 8.9% (263)
sCr before surgery (mmol · L-1) 95.8 ± 59.8
Previous stroke 5.6% (165)
COPD 12.0% (354)
Active smokers 15.5% (458)
Previous Atrial fibrillation 23.9% (703)
Previous myocardial infarction 15.4% (454)
Recent myocardial infarction 11.1% (325)
NYHA class III-IV 15.3% (450)
On B-Blockers 41.0% (1,204)
On statins 41.2% (1,212)
On aspirin 44.4% (1,306)
On diuretics 47.6% (1,398)
Hypertrophic cardiomyopathy 30.9% (910)
Dilated cardiomyopathy 20.4% (600)
LVEF (%) 60.2 ± 11.9
PAP (mmHg) 45.9 ± 15.7
Hemoglobin before surgery (g · dL-1) 12.9 ± 1.7
Platelet count before surgery(1 · nL-1) 215 ± 68
EuroSCORE 5.9 ± 3.0
Parsonnet score 11.5 ± 7.3
Past cardiac surgery 9.4% (277)
BMI, Body Mass Index; COPD, Chronic Obstructive Pulmonary Disease; NYHA, New Y
Pulmonary arterial pressure; sCr, serum creatinine;. Data are mean ± standard deviat
Boldface data are statistically significant (P <0.05).adjusting for preoperative and postoperative scores. Re-
ceiver operating characteristic (ROC) curve analyses were
applied to check the optimal cut-off values of the differ-
ent scores for AKI diagnosis and to further evaluate the
predictive power between them, considering the differ-
ences between the areas under the empirical ROC curves
(AUC). ANOVA was used to compare differences in
characteristics and outcome differences between different
RIFLE class groups (P shown in tables) and subsequent
post hoc tests (Bonferroni tests) were used to determine
significant differences in the various pairwise compari-
sons (P shown in results). This was confirmed by means
or a multivariate analysis after adjusting for preoperativeith the presence of AKI after cardiac surgery
Non-AKI patients AKI patients P-value
(n = 2,531; 86%) (n = 409; 14%)
64.4% (1,631) 61.1% (250) 0.20
35.6% (900) 38.9% (159) 0.20
64.0 ± 11.8 67.7 ± 9.8 <0.001
62.1% (1,570) 67.5% (276) 0.03
51.4% (1,301) 44.9% (183) 0.01
7.9% (200) 10% (41) 0.14
28.4 ± 4.3 27.9 ± 4.5 0.90
7.9% (200) 15.4% (63) <0.001
94.0 ± 60.0 101.0 ± 56.0 0.045
5.2% (131) 8.3% (34) 0.015
11.6% (294) 14.7% (60) 0.08
15.8% (402) 13.7% (56) 0.29
22.5% (569) 32.8% (134) 0.045
16.0% (404) 12.2% (50) 0.055
11.0% (278) 11.5% (47) 0.73
15.3% (389) 14.9% (61) 0.79
41.8% (1,057) 35.9% (147) 0.026
42.6% (1,078) 32.8% (134) <0.001
45.7% (1,156) 36.7% (150) 0.001
46.0% (1,165) 57.0% (233) <0.001
31.2% (790) 29.3% (120) 0.35
20.1% (508) 22.5% (92) 0.34
60.1 ± 11.8 60.3 ± 12.2 0.83
45.3 ± 15.0 48.0 ± 17.0 0.003
13.0 ± 1.6 12.4 ± 1.9 <0.001
217 ± 67 206 ± 76 0.005
5.6 ± 2.7 7.7 ± 3.5 0.015
10.9 ± 6.8 14.5 ± 9.3 0.001
8.4% (213) 15.6% (64) <0.001
ork Heart Association classification; LVEF, Left ventricular ejection fraction; PAP,
ion or percentage.
Table 2 Univariate analysis of intraoperative and postoperative data associated with the presence of AKI after
cardiac surgery
All patients Non-AKI patients AKI patients P-value
(n = 2,940) (n = 2,531; 86%) (n = 409; 14%)
Intraoperative data
Isolated CABG 32.1% (945) 33.6% (851) 23.0% (94) 0.005
Isolated valve surgery 51.6% (1,518) 51.8% (1,311) 51.6% (207) 0.85
CABG + valve surgery 6.9% (203) 6.2% (158) 11.0% (45) <0.001
Other cardiac surgery 9.4% (274) 8.4% (211) 15.4% (63) <0.001
Emergent surgery 5.1% (149) 3.9% (99) 12.2% (50) <0.001
Number of bypass 2.3 ±0.9 2.3 ± 0.8 2.2 ± 0.9 0.68
ACC time (minutes) 73 ± 29 72 ± 28 87 ± 37 <0.001
CPB time (minutes) 113 ± 41 109 ± 37 135 ± 55 <0.001
Postoperative data
Ventilation time (hours) 50 ± 127 36 ± 96 139 ± 229 <0.001
PaO2/FiO2 ratio on admission 331 ± 98 334 ± 96 315 ± 106 0.001
PaO2/FiO2 ratio 12 h after admission 311 ± 89 316 ± 87 278 ± 93 <0.001
PaO2/FiO2 ratio 24 h after admission 307 ± 77 314 ± 72 270 ± 90 <0.001
Reintubation 1.1% (31) 0.8% (21) 2.5% (10) 0.001
Tracheostomy 1.3% (38) 0.8% (19) 4.7% (19) 0.001
Need of vasoactive drugs (hours) 103 ± 141 82 ± 110 195 ± 210 <0.001
LCOS 41.6% (1,223) 36.3% (920) 74.1% (303) <0.001
PMI 11.8% (346) 10% (252) 23% (94) <0.001
IABP support 7.8% (230) 6.1% (155) 18.3% (75) <0.001
Atrial fibrilation 39.4% (1,158) 36.1% (913) 59.9% (245) <0.001
AL on admission (mmol · L-1) 2.3 ± 1.4 2.2 ± 1.2 3.1 ± 2.3 <0.001
AL 24 h after admission (mmol · L-1) 1.9 ± 1.0 1.8 ± 0.7 2.6 ± 1.9 <0.001
sCr peak after surgery (mmol · L-1) 114.3 ± 80.8 99.0 ± 62.0 205.0 ± 113.0 <0.001
Albumin 48 h after surgery (g · L-1) 28.2 ± 3.7 28.4 ± 3.6 26.5 ± 4.1 <0.001
Hemorrhage-related re-exploration 3.5% (103) 2.6% (66) 9.0% (37) <0.001
Pericardial tamponade 0.7% (22) 0.4% (11) 2.7% (11) <0.001
Drainage loss first 12 h (mL) 393 ± 301 377 ± 275 496 ± 414 <0.001
Major bleeding 3.6% (109) 2.6% (66) 10.5% (43) <0.001
Re-exploration 1.6% (48) 0.8% (21) 5.1% (27) <0.001
Need for blood products (units) 1.6 ± 3.0 1.4 ± 2.5 3.3 ± 4.6 <0.001
Stroke 1.4% (42) 0.9% (24) 4.4% (18) <0.001
Septicemia 6.6% (195) 4.0% (102) 22.7% (93) <0.001
SAPS II 24.2 ± 9.6 22.8 ± 8.3 32.3 ± 12.8 <0.001
SAPS III 39.9 ± 10.4 38.6 ± 9.4 48.4 ± 12.3 <0.001
APACHE II 12.3 ± 4.6 11.6 ± 4.0 16.1 ± 6.3 <0.001
APACHE III 49.9 ± 18.5 47.0 ± 15.0 67.0 ± 24.0 <0.001
Mean Pre-ICU stay (days) 7.0 ± 13.0 6.7 ± 8.6 8.7 ± 28.8 0.15
Mean ICU stay (days) 7.5 ± 11.0 6.2 ± 7.7 15.2 ± 20.3 <0.001
Mean hospital stay (days) 24.6 ± 22.5 22.8 ± 15.7 36.1 ± 44.5 <0.001
In-hospital mortality 6.0% (177) 2.4% (60) 28.6% (117) <0.001
ACC, Aortic cross clamping; AL, Arterial lactate; APACHE, Acute Physiology and Chronic Health Evaluation; CABG, Coronary artery bypass graft; CPB, Cardiopulmonary
bypass; IABP, intra-aortic balloon pump; LCOS, Low Cardiac Output Syndrome; PaO2/FiO2, Arterial partial pressure of O2 and fraction of inspired oxygen ratio; PMI,
Perioperative myocardial infarction; SAPS, Simplified Acute Physiology Score; sCr, serum creatinine. Data are mean ± standard deviation or percentage.
Boldface data are statistically significant (P <0.05).
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Smirnov test was used to check the normal distribution
of our population and to assess the goodness-of-fit of the
final regression models. Survival analysis was carried out
with the Kaplan-Meier estimator for the different RIFLE
class groups. A proportional hazards Cox regression
model was used to evaluate the effect of AKI and RIFLE
class groups on survival. A two-tailed P-value <0.05 was
considered statistically significant.
Results
Risk factors and scores prediction of AKI
The results of the univariate analysis of preoperative, in-
traoperative and postoperative data are shown in Tables 1
and 2. The 14% of patients (n = 409) who were diagnosed
with AKI were older and more likely to have associated
comorbid conditions and postoperative complications
with a higher risk prediction for in-hospital mortality
based on preoperative and postoperative scores than
those without AKI.
In Table 3, we compare the results of the multivariate
analysis of AKI based on different variable categories
included in each analysis. We performed an adjustment
for these scores in order to avoid the influence of sever-
ity of illness at the time of cardiac surgery and/or ICU
admission. The preoperative data (older age, presence
of peripheral vascular disease, higher pulmonary ar-
terial pressure in preoperative echocardiography, and
lower hemoglobin before surgery), intraoperative data
(higher cardiopulmonary bypass (CPB) time and emergentTable 3 Logistic regression model - dependent variable
presence of AKI
Odds ratio (95% CI) P-value
Preoperative data
Age 1.038 (1.021 to 1.055) <0.001
Presence of peripheral vascular disease 1.403 (0.991 to 1.987) 0.003
PAP (mmHg) 1.012 (1.002 to 1.022) 0.020
Hemoglobin before surgery (g · dL-1) 0.856 (0.783 to 0.936) 0.001
Intraoperative data
CPB time (minutes) 1.013 (1.010 to 1.016) <0.001
Emergent surgery 1.273 (1.168 to 1.444) <0.001
Postoperative data
Need of vasoactive drugs (hours) 1.005 (1.001 to 1.008) 0.001
AL 24 h after admission 1.530 (1.293 to 1.819) <0.001
All data
Need of vasoactive drugs (hours) 1.003 (1.002 to 1.004) <0.001
AL 24 h after admission 1.810 (1.300 to 2.015) <0.001
CPB time (minutes) 1.012 (1.002 to 1.028) 0.025
AL, Arterial lactate; CPB, Cardiopulmonary bypass; PAP, Pulmonary arterial
pressure; sCr, Serum creatinine.
Boldface data are statistically significant (P <0.05).surgery), and postoperative data (a longer need for
vasoactive drugs and higher arterial lactate 24 h after
admission) were associated with the occurrence of AKI
when we analyzed these different variable categories separ-
ately. However, when assessing all data collected simultan-
eously, only postoperative variables and a higher CPB time
were associated with the occurrence of AKI.
When we assessed the ability of cardiac surgery and
ICU scores to predict AKI (see Table 4), we found that
cardiac surgery scores were poor predictors of AKI devel-
opment whereas ICU scores were fair predictors based on
the ROC curve.
Differences between RIFLE groups
The differences between RIFLE groups showed a com-
parable univariate association of the majority of outcome
variables with worse outcome according to increased
severity of AKI (see Tables 5 and 6). Preoperative vari-
ables showed lower hypertension rates in the RIFLE
risk (RIFLE-R) group compared with the RIFLE failure
(RIFLE-F) group and lower diabetes mellitus rates com-
pared with the RIFLE injury (RIFLE-I) group. The RIFLE-F
group suffered from higher CPB times compared with
RIFLE-R (Bonferroni post hoc P <0.001) during cardiac sur-
gery. Postoperative variables showed higher albumin levels
48 h after cardiac surgery in the RIFLE-R (P <0.001) and
RIFLE-I (P = 0.019) groups when compared with RIFLE-F.
The RIFLE-F and RIFLE-I groups showed a longer need
for vasoactive drugs (P <0.001 in both groups) and higher
in-hospital mortality rates (P = 0.001 and P = 0.003, re-
spectively) when compared with the RIFLE-R group. Fi-
nally, the RIFLE-R group showed lower Low Cardiac
Output Syndrome (LCOS) and septicemia rates compared
with the RIFLE-F group. All these comparisons were con-
firmed later by means of the logistic regression model ad-
justed for risk prediction scores (see Table 7).
Mortality and survival analysis
A Cox proportional hazards model for patients’ in-
hospital mortality demonstrated that staging at RIFLE-I
(hazard ratio (HR) = 2.347, 95% confidence interval (CI)
1.122 to 4.907, P = 0.023) and RIFLE-F (HR = 3.093, 95%
CI 1.460 to 6.550, P = 0.003) were independent predictors
for patient mortality. Other factors associated with an in-
creased risk of death included older age (HR = 1.080, 95%
CI 1.036 to 1.126, P <0.001), diabetes mellitus (HR = 1.376,
95% CI 1.178 to 1.795, P = 0.01), longer time on vasoactive
drugs (HR = 1.003, 95% CI 1.001 to 1.004, P <0.001) and
suffering a stroke after cardiac surgery (HR = 1.130, 95% CI
1.045 to 1.376, P <0.001).
We performed a complete follow-up in order to evaluate
long-term mortality in 2,840 patients. Mean follow-up was
6.9 ± 4.3 years. Kaplan-Meier plots, shown in Figures 1
and 2, illustrated that patients with AKI and a higher
Table 5 Differences in preoperative data between AKI subgroups based on RIFLE classification
AKI patients RIFLE risk RIFLE injury RIFLE failure P-value
(n = 409) (n = 226; 55.2%) (n = 87; 21.3%) (n = 96; 23.5%)
Sex (male) 61.1% (250) 58.8% (133) 57.5% (50) 69.8% (67) 0.12
Sex (female) 38.9% (159) 41.2% (93) 42.5% (37) 30.2% (29) 0.13
Age (years) 67.7 ± 9.8 67.3 ± 10.0 68.1 ± 10.4 68.1 ± 8.9 0.68
Hypertension 67.5% (276) 62.8% (142) 69.0% (60) 77.1% (74) 0.042
Dyslipidemia 44.9% (183) 39.4% (89) 46.0% (40) 56.3% (54) 0.02
Diabetes mellitus 10.0% (41) 7.5% (17) 17.2% (15) 9.4% (9) 0.036
BMI (kg · m-2) 27.9 ± 4.4 27.8 ± 4.3 28.2 ± 4.1 27.9 ± 5.3 0.77
Peripheral vascular disease 15.4% (63) 13.3% (30) 14.9% (13) 20.8% (20) 0.22
sCr before surgery (mmol · L-1) 101 ± 56 86 ± 31 91 ± 30 115 ± 48 <0.001
Previous stroke 8.3% (34) 7.5% (17) 10.3% (9) 8.3% (8) 0.72
COPD 14.7% (60) 14.2% (32) 17.2% (15) 13.5% (13) 0.74
Active smokers 13.7% (56) 10.2% (23) 19.5% (17) 16.6% (16) 0.43
Previous atrial fibrillation 32.8% (134) 31.4% (71) 31.0% (27) 37.5% (36) 0.61
Previous myocardial infarction 12.2% (50) 11.5% (26) 13.8% (12) 12.5% (12) 0.85
Recent myocardial infarction 11.5% (47) 8.8% (20) 14.9% (13) 14.6% (14) 0.17
NYHA class III-IV 14.9% (61) 15.1% (34) 14.9% (13) 14.6% (14) 0.82
On B-blockers 35.9% (147) 35.4% (80) 41.4% (36) 32.3% (31) 0.42
On statins 32.8% (134) 29.2% (66) 39.1% (34) 35.4% (34) 0.21
On aspirin 36.7% (150) 34.1% (77) 41.4% (36) 38.5% (37) 0.44
On diuretics 57.0% (233) 52.7% (119) 63.2% (55) 61.5% (59) 0.14
Hypertrophic cardiomyopathy 29.3% (120) 27.8% (63) 27.5% (24) 34.3% (33) 0.37
Dilated cardiomyopathy 22.5% (92) 20.8% (47) 25.3% (22) 23.9% (23) 0.65
LVEF (%) 60.0 ± 12.2 60.8 ± 11.7 58.7 ± 13.7 60.7 ± 11.8 0.41
PAP (mmHg) 48.0 ± 17.0 46.4 ± 16.9 51.9 ± 16.7 52.0 ± 16.9 0.07
Hemoglobin before surgery (g · dL-1) 12.4 ± 1.9 12.7 ± 1.8 12.2 ± 1.8 12.1 ± 2.1 0.009
Platelet count before surgery (1 · nL-1) 206 ± 76 206 ± 77 206 ± 75 205 ± 73 0.98
EuroSCORE 7.7 ± 3.5 7.1 ± 3.0 7.9 ± 3.6 8.8 ± 4.0 0.028
Parsonnet score 14.5 ± 9.3 13.1 ± 7.7 14.3 ± 7.8 18.5 ± 12.8 <0.001
Past cardiac surgery 15.6% (64) 17.3% (39) 11.5% (10) 15.6% (15) 0.45
AKI, Acute Kidney Injury; BMI, Body Mass Index; COPD, Chronic Obstructive Pulmonary Disease; LVEF, Left ventricular ejection fraction; NYHA, New York Heart
Association classification; PAP, Pulmonary arterial pressure; sCr, serum creatinine. Data are mean ± standard deviation or percentage.
Boldface data are statistically significant (P <0.05).
Table 4 Comparison of AUC for ICU and cardiac surgery scores for AKI prediction
AUC ± SD% (95% CI) Cut-off levels Sensitivity Specificity P-value
APACHE II 71.0 ± 2.4 (66.4 to 75.6) 13.5 67.1% 64.7% <0.001
APACHE III 75.8 ± 2.2 (71.4 to 80.1) 54.5 73.0% 67.1% <0.001
SAPS II 72.3 ± 2.3 (67.7 to 76.9) 26.5 67.8% 65.7% <0.001
SAPS III 72.0 ± 2.2 (67.6 to 76.3) 42.5 70.4% 61.9% <0.001
EuroSCORE 67.6 ± 2.3 (63.0 to 72.2) 5.5 71.1% 53.8% <0.001
Parsonnet 61.9 ± 2.5 (57.0 to 66.8) 11.5 61.8% 54.6% <0.001
APACHE, Acute Physiology and Chronic Health Evaluation; AUC, Area under curve; EuroSCORE, European system for cardiac operative risk evaluation; SAPS,
Simplified Acute Physiology Score.
Boldface data are statistically significant (P <0.05).
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Table 6 Differences in intraoperative and postoperative data between AKI subgroups based on RIFLE classification
AKI patients RIFLE risk RIFLE injury RIFLE failure P-value
(n = 409) (n = 226; 55.2%) (n = 87; 21.3%) (n = 96; 23.5%)
Intraoperative data
Isolated CABG 23% (94) 22.1% (50) 26.4% (23) 21.9% (21) 0.87
Isolated valve surgery 51.6% (207) 51.3% (116) 49.4% (43) 50.0% (48) 0.82
CABG + valve surgery 11% (45) 12.8% (29) 4.6% (4) 12.5% (12) 0.32
Other cardiac surgery 15.4% (63) 13.7% (31) 19.5% (17) 15.6% (15) 0.68
Emergent surgery 12.2% (50) 9.3% (21) 7% (8) 22.9% (22) 0.004
Number of bypass 2.29 ± 0.92 2.3 ± 0.9 2.5 ± 0.8 2.1 ± 1.0 0.21
ACC time (minutes) 87 ± 37 81 ± 32 96 ± 41 92 ± 39 0.004
CPB time (minutes) 135 ± 55 123 ± 44 147 ± 64 151 ± 62 <0.001
Postoperative data
Ventilation time (hours) 139 ± 229 84 ± 176 204 ± 264 209 ± 268 <0.001
PaO2/FiO2 ratio on admission 315 ± 106 325 ± 105 320 ± 85 310 ± 115 0.01
PaO2/FiO2 ratio 12 h after admission 278 ± 93 300 ± 85 290 ± 105 270 ± 96 0.003
PaO2/FiO2 ratio 24 h after admission 270 ± 90 295 ± 78 259 ± 91 221 ± 94 <0.001
Reintubation 2.5% (10) 1.8% (4) 3.4% (3) 3.2% (3) 0.08
Tracheostomy 4.7% (19) 4.1% (9) 8.0% (7) 3.2% (3) 0.01
Need of vasoactive drugs (hours) 195 ± 210 137 ± 149 242 ± 207 267 ± 274 <0.001
LCOS 74.1% (303) 62.4% (141) 87.3% (76) 89.5% (86) <0.001
PMI 23.0% (94) 14.6% (33) 28.7% (25) 37.5% (36) <0.001
IABP support 18.3% (75) 15.9% (36) 16.0% (14) 26.1% (25) 0.04
Atrial fibrilation 59.9% (245) 52.2% (118) 64.4% (56) 74.0% (71) <0.001
AL on admission (mmol · L-1) 3.1 ± 2.3 3.1 ± 2.2 2.9 ± 3.3 3.3 ±2.5 0.11
AL 24 h after admission (mmol · L-1) 2.6 ± 1.9 2.2 ±1.3 2.7 ± 1.7 3.3 ± 2.7 <0.001
sCr peak after surgery (mmol · L-1) 205 ± 113 143 ± 52 214 ± 72 342 ± 126 <0.001
Albumin 48 h after surgery (g · L-1) 26.5 ± 4.1 27.0 ± 3.4 26.0 ± 3.5 24.0 ± 5.0 <0.001
Hemorrhage-related re-exploration 9.0% (37) 5.3% (12) 13.8% (12) 13.5% (13) 0.014
Pericardial tamponade 2.7% (11) 2.2% (5) 2.3% (2) 4.2% (4) 0.59
Drainage loss first 12 h (mL) 496 ± 414 448 ± 368 523 ± 498 581 ± 422 0.026
Major bleeding 10.5% (43) 10.1% (23) 10.3% (9) 11.4% (11) 0.65
Re-exploration 5.1% (27) 4.4% (10) 4.6% (4) 13.5% (13) 0.001
Need for blood products (Units) 3.3 ± 4.6 2.6 ± 4.2 4.23 ± 4.9 4.3 ± 4.9 0.001
Stroke 4.4% (18) 3.1% (7) 3.4% (3) 8.3% (8) 0.09
Septicemia 22.7% (93) 13.2% (30) 27.5% (24) 40.6% (39) <0.001
SAPS II 32.3 ± 12.8 27.7 ± 9.5 34.4 ± 13.0 40.9 ± 14.4 <0.001
SAPS III 48.4 ± 12.3 44.1 ± 9.9 49.2 ± 11.5 56.9 ± 13.2 <0.001
APACHE II 16.1 ± 6.3 13.7 ± 4.3 17.0 ± 6.8 20.9 ± 7.1 <0.001
APACHE III 67.0 ± 24.0 58.4 ± 17.4 69.6 ± 23.4 86.0 ± 27.5 <0.001
Mean Pre-ICU stay (days) 8.7 ± 28.8 6.2 ± 7.8 7.7 ± 9.3 15.7 ± 57.3 0.023
Mean ICU stay (days) 15.2 ± 20.3 12.0 ± 15.8 18.0 ± 22.8 20.3 ± 25.4 0.001
Mean hospital stay (days) 36.1 ± 44.5 31.5 ± 34.2 38.5 ± 32.0 44.6 ± 68.0 0.046
In-hospital mortality 28.6% (117) 10.6% (24) 42.5% (37) 58.3% (56) <0.001
ACC, Aortic cross clamping; AL, Arterial lactate; APACHE, Acute Physiology and Chronic Health Evaluation; CABG, Coronary artery bypass graft; CPB, Cardiopulmonary
bypass; IABP, Intra-aortic balloon pump; LCOS, Low Cardiac Output Syndrome; PaO2/FiO2, Arterial partial pressure of O2 and fraction of inspired oxygen ratio; PMI,
Perioperative myocardial infarction; SAPS, Simplified Acute Physiology Score; sCr, Serum creatinine. Results are expressed as mean ± standard deviation or percentage.
Boldface data are statistically significant (P <0.05).
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Table 7 Differences between RIFLE groups in a logistic
regression model
Odds ratio (95% CI) P-value
RIFLE risk vs RIFLE failure
Hypertension 1.299 (1.098 to 1.916) 0.034
Cardiopulmonary bypass time (minutes) 1.014 (1.003 to 1.025) 0.014
Need of vasoactive drugs (hours) 1.003 (1.000 to 1.006) 0.004
Albumin 48 h after surgery (g · L-1) 0.858 (0.764 to 0.964) 0.010
Low cardiac output syndrome 1.144 (1.039 to 1.534) 0.004
Septicemia 1.078 (1.019 to 1.321) <0.001
In-hospital mortality 1.856 (1.198 to 3.028) 0.001
RIFLE risk vs RIFLE injury
Diabetes mellitus 1.323 (1.116 to 1.901) 0.031
Need of vasoactive drugs (hours) 1.002 (1.000 to 1.004) 0.045
In-hospital mortality 1.656 (1.360 to 2.980) 0.003
RIFLE injury vs RIFLE failure
Albumin 48 h after surgery (g · L-1) 0.896 (0.828 to 0.969) 0.006
Boldface data are statistically significant (P <0.05).
Figure 1 Kaplan-Meier survival curves for the presence of AKI.
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up period (see also Table 8). The long-term survival
was similar regardless of type of surgery, as shown in
Figure 3A, B. A Cox proportional hazards model of
patient mortality demonstrated that AKI in isolated coron-
ary artery bypass graft (CABG) procedures (HR = 3.706,
95% CI 2.012 to 6.875, P <0.001) and valve surgery pro-
cedures (HR = 2.713, 95% CI 1.980 to 5.250, P <0.001)
was an independent predictor of mortality in these sur-
gical groups. We observed a long-term global mortality
of 11.74% (n = 313/2,665), after excluding patients who
died in-hospital and those who survived but in whom
follow-up could not be performed. In addition, in the
long-term scenario mortality was 10.6% in non-AKI
patients (n = 253/2,384), 21.4% (n = 60/281) in AKI pa-
tients, 15.9% (n = 31/195) in RIFLE-R, 25% (n = 12/48) in
RIFLE-I, and 44.7% (n = 17/38) in RIFLE-F (P <0.001).
Discussion
This study shows the key importance of postoperative
factors, which can be easily monitored, for predicting
the occurrence of AKI after cardiac surgery. Thus, a
prompt intervention in the postoperative management
in the ICU, especially avoiding additional renal insults
and optimizing volume status, may help to some extent
to prevent a higher progression of perioperative AKI,
and the occurrence of the worst outcomes, including in-
hospital mortality, is associated with the worst RIFLE
class. We also demonstrated that scoring systems based
only on variables known preoperatively, such as the
Parsonnet and EuroSCORE, which have been proposed
for the assessment of AKI developing after adult cardiacsurgery [12], are worse predictors than ICU scores, which
mainly included variables known postoperatively. Finally, a
modified RIFLE classification is associated with long-term
mortality, especially when staging within the RIFLE-I and
RIFLE-F groups.
Although sCr is not always a perfect surrogate of renal
function, it continues to be a basic measurement for the
classification and diagnosis of AKI [8]. A ≥10% reduction
in the sCr level may predict significantly lower AKI risk,
whereas a ≥10% increase may predict significantly higher
AKI risk compared with the reference category, reflect-
ing the fact that minimal changes in sCr can increase
mortality after cardiac surgery [4,13]. Novel biomarkers,
such as neutrophil gelatinase-associated lipocalin and
cystatin C, have been correlated with the duration and
severity of AKI and the duration of ICU stay after adult
cardiac surgery, and have been identified as independent
predictors of AKI, being superior to conventional bio-
markers [14]. However, due to its availability and wide-
spread use, sCr continues to be a more valuable and
accepted tool for AKI diagnosis worldwide.
Hyperlactatemia in the ICU is associated with in-
creased mortality, being more frequent when renal fail-
ure is present [15]. It predicts postoperative mortality
after cardiac surgery with a maximum lactate threshold
of ≥4.4 mmol · L-1 in the first 10 h after operation [16].
During CPB the kidneys may suffer from an imbalance
between oxygen supply and oxygen needs, resulting in
inadequate oxygen delivery that is associated with lactate
production [17]. The duration of CPB, which is a surro-
gate of the complexity of the procedure or of unex-
pected intraoperative problems, and its related variables,
such as pressures and flows, have also been associated
with AKI [1,18,19]. This may explain why higher arterial
lactate values, which are ultimately a surrogate marker
of tissue hypoperfusion, and a longer CPB duration,
Figure 2 Kaplan-Meier survival curves for the different AKI groups.
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oxygen delivery depends on an appropriate hemoglobin
level [17], being consistent with our finding that lower
hemoglobin before surgery was associated with AKI.
Previous studies that found preoperative anemia, hemo-
dilution and perioperative red blood cell transfusions to
be associated with AKI are also consistent with this find-
ing [19,20]. As a consequence, intraoperative avoidance
of the extremes of anemia, especially during CPB, and
avoidance of transfusion in patients with hemoglobin
levels >8 g · dL-1, may be helpful strategies in order to de-
crease AKI in patients undergoing cardiac surgery [21,22].
Despite the relationship between heart failure and
renal insufficiency, even in the acute scenario [23], there
is a lack of studies associating heart failure variables
and/or related variables with AKI after cardiac surgery
[24]. The postoperative use of norepinephrine in postoper-
ative cardiac surgery patients and the postoperative use of
vasoactive drugs in those with sCr <60 mL ·minute-1 ·
1.73 m-2 has been associated with AKI [19]. We hypothe-
sized that a longer requirement for vasoactive drugs, even
with a higher RIFLE class, is a variable concerning the peri-
operative drug management of patients, and could be aTable 8 Survival rates during follow-up for the different AKI g
RIFLE class 1-year 2-years 3-years 4-years
Risk 88% 84% 82% 77%
Injury 55% 48% 46% 45%
Failure 39% 30% 25% 24%surrogate marker of unresolved postoperative cardiac or
vascular dysfunction.
We confirmed the association of worse outcomes, in-
cluding in-hospital mortality, with a worse RIFLE class,
which may ultimately contribute to AKI. Limited CPB
duration and adequate cardiac output are of key import-
ance in order to avoid AKI development [25]. Hypoalbu-
minemia also increased the risk for infection in cardiac
surgery patients, which itself is an important risk factor
for mortality after cardiac surgery [26]. Sepsis can induce
cardiac dysfunction per se [27], being associated with
AKI and mortality after cardiac surgery [28,29]. As a
result, our findings are concordant with the literature in
relation to the associated AKI factors described above.
The RIFLE classification provides a useful tool for
identifying patients with AKI after cardiac surgery and
as a consequence those at risk of death, even in the
long-term scenario [1-4], being superior to the classical
postoperative renal failure definition in identifying such
patients [11]. The present report is the first detailing the
important association between long-term mortality after
cardiac surgery and RIFLE-I and RIFLE-F classes in a
large, single-center cohort, defined by a modified RIFLEroups
5-years 6-years 7-years 8-years 9-years
75% 73% 72% 68% 68%
45% 42% 39% 39% 39%
23% 23% 20% 20% 20%
Figure 3 Kaplan-Meier survival curves for AKI patients stratified by individual surgery type (A and B).
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independent predictor of outcome regardless of type of sur-
gery, being more important in isolated CABG procedures,
as previously reported, but with greater influence over valve
surgery compared with other studies [2]. Peripheral vascular
disease leads to endothelial dysfunction, which is associated
with renal insufficiency and contributes to cardiovascular
mortality [30]. We hypothesized that a higher influence of
arteriosclerosis in CABG patients is also associated with
peripheral vascular disease and with vascular damage in
renal vessels, which ultimately predisposes to AKI.
Renal blood flow and clearance function can remain
impaired for a prolonged period of time after an episode
of AKI, despite apparent normalization of sCr [31]. In-
deed, several studies have indicated that there is ongoing
progressive damage after AKI that results in a decrease
in the capillary density of peritubular capillaries, a
process known as “rarefaction” that can be linked to the
development of chronic kidney disease, often with a de-
layed increase in sCr [32]. We can only hypothesize that
the development of chronic kidney disease is one of the
potential mechanisms that exposes these patients to
increased cardiovascular morbidity and mortality [33].
Although comparisons among other studies remain diffi-
cult due to the different definitions and incidence of AKI,
our survival rates for both AKI and non-AKI groups are
comparable with other studies [2].
Our study presents certain limitations. The most im-
portant is that it was a single-center observational study.
Unfortunately, we were not able to collect information
on the cause of death and progression of kidney disease
either. Among the strengths of this study are the large
sample size, the prospective entry of all data elements
into the database and the use of the finest statisticalmodels together with systematic risk assessment using
preoperative and postoperative scores, which are not
shown in contemporary studies, even since the wide-
spread use and importance of risk score stratification
during the last decades. Furthermore, this investigation
was conducted at a large tertiary referral hospital with a
high level of complexity and all types of surgery, and all
patients underwent surgery with CPB.
Conclusions
In summary, the cause of AKI in the postoperative
period, which is usually multifactorial, could be associ-
ated to a large extent with postoperative variables. In
most cases, such variables lead to worse RIFLE staging
when AKI occurs. The occurrence of AKI, especially sta-
ging at the RIFLE-I and RIFLE-F class, is associated with
higher long-term mortality in our population.
The identification of postoperative AKI predictors
could be of great clinical value, suggesting management
changes that could prevent or reduce the impact of AKI
itself and guiding ICUs in allocating resources for post-
operative care before more severe complications occur.
In addition, on the basis of this and previous studies
[2,31-33], we suggest that patients suffering AKI after
cardiac surgery should be closely followed in order to
detect progressive renal damage beyond the acute
episode, despite apparent normalization of sCr.
Key messages
 The occurrence of AKI in the postoperative period
of cardiac surgery continues to be a crucial factor
which influences the outcome these patients, even
from the long-term perspective.
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with postoperative variables, which ultimately could
lead to a worse RIFLE class.
 Staging at the RIFLE injury and RIFLE failure class
is associated with higher short- and long-term
mortality in our population.
 The identification of postoperative AKI predictors
could help clinicians in order to prevent the impact
of AKI itself and guiding ICUs in allocating
resources for postoperative care.
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